Artemisia in the Gerson Therapy: Tarragon, Wormwood and Cancer-Causing Parasites

The Artemisia family includes some of the best-known medicinal plants in the world: wormwood, the bitter herb of absinthe; sweet wormwood, the source of the malaria drug artemisinin; and tarragon, a kitchen herb. Because some parasites are proven causes of cancer, and because Artemisia compounds are studied against parasites, a natural question is whether Artemisia is part of the Gerson Therapy's approach to cancer.

This page sets out what the Gerson books and the Gerson Institute actually list, how the Gerson books treat parasites, which parasites are classified as causes of cancer, and what the research shows about Artemisia plants and drugs against those parasites and against cancer.


Table of Contents

  1. At a Glance
  2. The Artemisia Family: Tarragon, Wormwood and Sweet Wormwood
  3. Where Artemisia Appears in the Gerson Therapy
  4. How the Gerson Books Treat Parasites
  5. Which Parasites Cause Cancer
  6. Artemisinin Drugs Against Cancer-Causing Parasites
  7. Wormwood Itself Against Parasites
  8. Tarragon's Own Research
  9. Artemisinin and Cancer Itself
  10. What the Evidence Shows Overall
  11. Key Research Papers
  12. Connections
  13. Featured Videos

At a Glance

Back to Table of Contents

The Artemisia Family: Tarragon, Wormwood and Sweet Wormwood

The three plants share a genus name but are used very differently:

Back to Table of Contents

Where Artemisia Appears in the Gerson Therapy

In the Gerson book. The Gerson Therapy by Gerson and Walker, following Dr. Gerson's 1958 instructions, says that the aromatics in herbs and spices interfere with the healing response, so herbs are limited to small quantities of relatively mild ones. Tarragon is on that list, together with allspice, anise, bay leaf, coriander, dill, fennel, mace, marjoram, rosemary, sage, saffron, thyme, sorrel and summer savory; basil and oregano are avoided for their high aromatic-acid content. The full lists are on the Foods Allowed and Forbidden page.

In the Gerson Institute's cookbook. The shopping list in the appendix of the Gerson Therapy Cookbook, posted by the Gerson Institute, includes tarragon among its herbs and spices, and its herb and spice pairing chart suggests tarragon with asparagus (with dill), beets (with horseradish, allspice, coriander and fennel) and kale (with dill, marjoram, thyme, allspice and coriander).

What is not there. Neither wormwood nor sweet wormwood appears in these lists. In the Gerson Therapy, Artemisia is present only as tarragon, in small amounts, as a flavoring.

Back to Table of Contents

How the Gerson Books Treat Parasites

Parasites do appear in the Gerson literature, but not as a target for herbs:

In each case the approach described is the Gerson program as a whole. No Artemisia preparation, and no other antiparasitic herb, is part of the protocol described in these books.

Back to Table of Contents

Which Parasites Cause Cancer

The link between some parasites and cancer is firmly established. The World Health Organization's International Agency for Research on Cancer reviewed biological agents in 2009 (summarised by Bouvard and colleagues in The Lancet Oncology), and three parasitic worms are classified in its Group 1 — "carcinogenic to humans" (as summarised by Feng and Cheng, 2017):

The full list and the evidence behind it are on Parasites Classified as Carcinogens, and other proposed links are on Other Suspected Parasite–Cancer Links.

Back to Table of Contents

Artemisinin Drugs Against Cancer-Causing Parasites

The Artemisia compounds with human evidence against these parasites are the artemisinin drugs made from sweet wormwood — prescription medicines, not the herb as a food or tea.

Schistosomes (blood flukes)

Liver flukes

Back to Table of Contents

Wormwood Itself Against Parasites

Back to Table of Contents

Tarragon's Own Research

Back to Table of Contents

Artemisinin and Cancer Itself

Separately from parasites, artemisinin drugs have been studied as possible cancer treatments. The most-cited human study is a 2015 randomized, double-blind, placebo-controlled pilot trial in the United Kingdom (Krishna and colleagues, EBioMedicine): 23 people awaiting bowel-cancer surgery received 14 daily doses of oral artesunate (200 mg) or placebo, and 20 completed the trial. Signs of tumour-cell death above the trial's threshold were seen in 67% on artesunate and 55% on placebo; over a median of 42 months, the cancer returned in 1 patient on artesunate and 6 on placebo. It was a small pilot, and a larger trial has not reported results. The details are on Artemisinin and Artesunate in Cancer Research.

These are studies of a purified drug at medicinal doses. They say nothing about tarragon as a seasoning.

Back to Table of Contents

What the Evidence Shows Overall

ArtemisiaIn the Gerson Therapy?Evidence against cancer-causing parasitesEvidence against cancer
TarragonYes — small amounts, as a flavoringNone; two laboratory studies against Leishmania onlyNone in people
WormwoodNoLaboratory and animal studies onlyNone in people
Sweet wormwood (artemisinin drugs)NoHuman trials: prevents schistosome infection and improves praziquantel's cure rate; artesunate failed against the liver fluke Opisthorchis viverriniOne small human pilot trial in bowel cancer; larger trials not yet reported

Taken together: the Gerson Therapy contains tarragon only as a mild seasoning, and no study shows that tarragon in food kills parasites or prevents cancer. The Artemisia compound with real human evidence against a cancer-causing parasite is artemisinin, a prescription drug made from a different plant, used against schistosomes — and it is not part of the Gerson protocol.

Back to Table of Contents

Key Research Papers

  1. Bouvard V, Baan R, Straif K, et al. (2009). A review of human carcinogens--Part B: biological agents. The Lancet. Oncology — PubMed PMID: 19350698
  2. Feng M, Cheng X (2017). Parasite-Associated Cancers (Blood Flukes/Liver Flukes). Advances in Experimental Medicine and Biology — PubMed PMID: 29052139
  3. Pérez del Villar L, Burguillo FJ, López-Abán J, et al. (2012). Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis. PloS One — PubMed PMID: 23029285
  4. Liu R, Dong HF, Guo Y, et al. (2011). Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis. Parasites & Vectors — PubMed PMID: 22004571
  5. Soukhathammavong P, Odermatt P, Sayasone S, et al. (2011). Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial. The Lancet. Infectious Diseases — PubMed PMID: 21111681
  6. Lam NS, Long X, Su XZ, et al. (2018). Artemisinin and its derivatives in treating helminthic infections beyond schistosomiasis. Pharmacological Research — PubMed PMID: 29727708
  7. Beshay EVN (2018). Therapeutic efficacy of Artemisia absinthium against Hymenolepis nana: in vitro and in vivo studies in comparison with the anthelmintic praziquantel. Journal of Helminthology — PubMed PMID: 28606189
  8. Naß J, Efferth T (2018). The activity of Artemisia spp. and their constituents against Trypanosomiasis. Phytomedicine — PubMed PMID: 30166103
  9. Obolskiy D, Pischel I, Feistel B, et al. (2011). Artemisia dracunculus L. (tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety. Journal of Agricultural and Food Chemistry — PubMed PMID: 21942448
  10. Rezaei R, Hazrati Tappeh K, Seyyedi S, et al. (2017). The Anti-leishmanial Efficacy of Artemisia dracunculus Ethanolic Extract in Vitro and Its Effects on IFN-γ and IL-4 Response. Iranian Journal of Parasitology — PubMed PMID: 28979350
  11. Mirzaei F, Bafghi AF, Mohaghegh MA, et al. (2016). In vitro anti-leishmanial activity of Satureja hortensis and Artemisia dracunculus extracts on Leishmania major promastigotes. Journal of Parasitic Diseases — PubMed PMID: 27876985
  12. Méndez-Del Villar M, Puebla-Pérez AM, Sánchez-Peña MJ, et al. (2016). Effect of Artemisia dracunculus Administration on Glycemic Control, Insulin Sensitivity, and Insulin Secretion in Patients with Impaired Glucose Tolerance. Journal of Medicinal Food — PubMed PMID: 27097076
  13. Krishna S, Ganapathi S, Ster IC, et al. (2015). A Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal Cancer. EBioMedicine — PubMed PMID: 26137537

Books and Gerson Institute Documents

PubMed Topic Searches

Back to Table of Contents

Connections


Educational information only, not medical advice. The Gerson Therapy is described here as its books and the Gerson Institute describe it. Artemisinin drugs are prescription medicines; parasitic infections and cancer are diagnosed and treated by clinicians.

Back to Table of Contents